s100a9 - OmicsDI

Show results for

Unknown (963)
Transcriptomics (287)
Genomics (187)
Proteomics (56)
Other (5)
Metabolomics (3)
Models (1)

Organisms

Mus musculus (158)
Homo sapiens (131)
Andropogon gerardi (36)
Bacteria (36)
Canis lupus familiaris (36)
Clostridium perfringens (36)
Cnidaria (36)
Cricetulus griseus (36)
Eukaryota (36)
Fasciola (36)
Hepatitis B virus (36)
Human betaherpesvirus 5 (36)
Japanese encephalitis virus group (36)
Madurella mycetomatis (36)
Mesocricetus auratus (36)
Rattus norvegicus (22)
Sus scrofa (5)
Rhizobium leguminosarum (4)
Macaca mulatta (2)
Staphylococcus aureus subsp. aureus str. Newman (1)
uncultured bacterium (1)
Streptococcus agalactiae (1)
mixed sample (1)
Caenorhabditis elegans (1)
Pseudomonas aeruginosa (1)
Campylobacter jejuni (1)
feces metagenome (1)
Bos taurus (1)
Mus (1)
Macaca fascicularis fascicularis (1)

Organisms

Homo sapiens (67)
Mus musculus (61)
Rattus norvegicus (5)
Sus scrofa (3)
Campylobacter jejuni (1)
Mus (1)
Macaca mulatta (1)
feces metagenome (1)
mouse gut metagenome (1)
Bos taurus (1)
unidentified (1)

Repository

biostudies-arrayexpress (181)
ENA (163)
geo (135)
pride (36)
iProX (11)
MassIVE (4)
MetaboLights (3)
PanoramaPublic (3)
BioModels (1)
EGA (1)
jPOST (1)

Tissue

Cell culture (5)
Blood plasma (4)
Feces (3)
Neutrophil (3)
Platelet (3)
Blood (2)
Blood platelet (2)
Blood serum (2)
Brain (2)
Colon (2)
Ileum (2)
Macrophage (2)
Aorta (1)
Biofilm (1)
Blood clot (1)
Bone marrow (1)
Cardiocyte (1)
Carotid artery (1)
Erythroblast (1)
Fibroblast (1)
Heart (1)
Leukocyte (1)
Liver (1)
Megakaryocyte progenitor cell (1)
Melanocyte (1)
Midbrain dopaminergic neuron (1)
Monocyte (1)
Myocardium (1)
Pancreas (1)
T cell (1)

Disease

Normal (2)
Cardiovascular system disease (2)
Crohn's disease (2)
Inflammatory bowel disease (2)
Ulcerative colitis (2)
Acute myocardial infarction (1)
Alcohol-associated liver disease (1)
Brain glioblastoma multiforme (1)
Central retinal vein occlusion (1)
Cerebrovascular disease (1)
Gastrointestinal system disease (1)
Lewy body dementia (1)
Myocardial ischemia (1)
Pancreatic cancer (1)
Pancreatic ductal adenocarcinoma (1)
Salivary gland disease (1)
Type 1 diabetes mellitus (1)

Technology Type

Mass Spectrometry (36)
Shotgun proteomics (18)
Bottom-up proteomics (10)
Data-dependent acquisition (5)
Gel-based experiment (4)
Mass spectrometry (3)
Data-independent acquisition (3)
DiaPASEF (1)
MSE (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (10)
Illumina HiSeq 2500 (7)
Illumina NovaSeq X (5)
NextSeq 2000 (5)
Illumina HiSeq 4000 (5)
Illumina HiSeq 2000 (4)
N/A (3)
Q Exactive (3)
BeadBug Benchtop homogenizer (2)
NextSeq 500 (2)
Liquid Chromatography MS - negative - reverse phase (2)
NextSeq 550 (Illumina). (1)
Molecular Biology laboratory (1)
Mammalian cell culture laboratory (1)
FastPrep-24 5G bead beater, Qubit Fluorometer (1)
12 well TC-treated plate, LETs buffer, dry ice (1)
454 GS FLX Titanium (1)
ScanArray [PerkinElmer] (1)
NA (1)
NextSeq 550 (1)
Q Exactive HF-X (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2025 (39)
2023 (29)
2026 (29)
2024 (28)
2013 (27)
2020 (22)
2014 (21)
2008 (21)
2015 (20)
2022 (19)
2012 (18)
2016 (15)
2011 (14)
2021 (14)
2010 (12)
2007 (8)
2019 (7)
2017 (7)
2009 (7)
2018 (4)
2005 (3)
2006 (2)

CHEBI ID

CHEBI:63999 (1)
CHEBI:90995 (1)
CHEBI:34159 (1)
CHEBI:184926 (1)
CHEBI:84549 (1)
CHEBI:170340 (1)
CHEBI:197368 (1)
CHEBI:197369 (1)
CHEBI:185779 (1)
CHEBI:172762 (1)
CHEBI:135821 (1)
CHEBI:180757 (1)
CHEBI:27423 (1)
CHEBI:159174 (1)
CHEBI:16214 (1)
CHEBI:160004 (1)
CHEBI:173286 (1)
CHEBI:185983 (1)
CHEBI:158820 (1)
CHEBI:196609 (1)
CHEBI:164479 (1)
CHEBI:158854 (1)
CHEBI:165804 (1)
CHEBI:163500 (1)
CHEBI:20096 (1)
CHEBI:174796 (1)
CHEBI:173157 (1)
CHEBI:196525 (1)
CHEBI:71052 (1)
CHEBI:169897 (1)

Metabolite Name

LXA4 (1)
15-deoxy-12-14-PGD2 (1)
12-HETrE (1)
15-deoxy-12-14-PGJ2 (1)
9-10-DiHOME (1)
12-13-DiHOME (1)
(2E)-N-[4-(acetylamino)phenyl]-3-phenylprop-2-enamide (1)
C27H40O11 (1)
FT-sulfoxide; C12H18F7NO5S2 (1)
Glu-CA (1)
[3-Methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate (1)
6-(2-hydroxyethyl)-6,6a-dihydroisoindolo[2,1-a]quinazoline-5,11-dione (1)
3-Nitropropionic acid (1)
Mls002702983 (1)
C13H23NO7 (1)
11-Methyl-2,7-bis(methylene)-6,12-dioxo-5,14-dioxatricyclo[9.2.1.0~4,8~]tetradec-1(13)-en-9-yl methacrylate (1)
Biflorin (Capraria) (1)
Trimethyl(2-{[3-[octadeca-9,12-dienoyloxy]-2-(octadecanoyloxy)propyl phosphonato]oxy}ethyl)azanium (1)
Austrobuxusin I (1)
Mls001140705 (1)
Sr 2640 (1)
Haploside C (1)
Trp-CA (1)
N-[(1E)-2-(4-hydroxy-3-methoxyphenyl)-1-azavinyl]-2-[(3,5-dioxo(2H,4H-1,2,4-tr iazin-6-yl))amino]acetamide (1)
(2-iminochromen-3-yl)-N-(4-methylphenyl)carboxamide (1)
Gamma-Homolinolenic acid (1)
N-O-Fluorophenylglycine (1)
2H-benzo[d]1,3-dioxolan-5-yl-N-(4,5-dimethyl(1,3-thiazol-2-yl))carboxamide (1)
2-methoxyethyl 4-(3-bromo-5-ethoxy-4-hydroxyphenyl)-2-methyl-5-oxo-7-phenyl-1, 4,6,7,8-pentahydroquinoline-3-carboxylate (1)
4-O-Methylphloroacetophenone (1)

First Public Date

2024 (31)
2025 (28)
2026 (20)
2023 (16)
2021 (15)
2020 (15)
2014 (14)
2022 (13)
2018 (4)
2019 (2)
2017 (2)
2015 (2)
2013 (1)

Modelling Approach

Computational model (1)

Lab affiliation

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel (2)
King's College London, British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK (2)
1. INSERM U1287, Université Paris-Saclay, Gustave Roussy Cancer Center, Villejuif, France 2. Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France (1)
Adelaide Proteomics Centre (1)
Baker Heart and Diabetes Institute, Aus (1)
Bioanalytical Research Labs, Department of Biosciences, University of Salzburg (1)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands and Netherlands Proteomics Center, Utrecht, The Netherlands (1)
Biomolecular characterization unit, Center for Sustainable Resource Science, RIKEN (1)
Boston College, Chemistry (1)
College of Biology, Hunan University, China (1)
Consultant Medical oncology (1)
Department of Biochemistry and Molecular Biology, University of Calgary, Alberta, Canada; Department of Physiology and Pharmacology, University of Calgary, Alberta, Canada; The Hotchkiss Brain Institute, University of Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, University of Calgary, Alberta, Canada (1)
Department of Cell Physiology and Metabolism, Faculty of medicine, University of Geneva (1)
Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX (1)
Department of Plasma Proteins, Sanquin-AMC Landsteiner Laboratory, Amsterdam, The Netherlands (1)
Dr Ainhoa Mielgo, Tumour Microenvironment Lab, Department of Molecular and Clincial Cancer Medicine, University of Liverpool (1)
HZAU (1)
Head of Proteomics (1)
Institute of Biomedical Chemistry, 119121 Moscow, 10 Pogodinskaya str., bld. 8, Russian Federation; tel.: +7 495 246 16 41; web: www.ibmc.msk.ru (1)
Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, China, 610052 (1)
Institute of Cellular Biology and Pathology (1)
Institute of Cellular Biology and Pathology "N. Simionescu", Proteomics Department, Bucharest, Romania (1)
Institute of Medical Biochemistry, Protein Core Facility, Medical University of Innsbruck, 6020 Innsbruck, Austria (1)
Instituto de Investigaciones Sanitarias de Santiago de Compostela (1)
Keck MS & Proteomics Resource at Yale School of Medicine (1)
King's British Heart Foundation Centre, King's College London, London, United Kingdom (1)
Laboratory of Biopolymers Structure, Intercollegiate Faculty of Biotechnology of University of Gdańsk and Medical University of Gdańsk, Poland (1)
Medizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, Bochum, Germany (1)
Molecular Proteomics, Baker Heart Inst., Australia (1)
Professor at Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India (1)

IsPrivate

False (1)

Submitter Keywords

FAIR-AIML (1)

Classification

bacteria (1)

Modification

Heavy form (1)
Heavy form - site K (1)
Medium form - site K (1)
Medium form - site N-term (1)

Study type

Transcription profiling by array (118)
RNA-seq of coding RNA (25)
Methylation profiling by high throughput sequencing (10)
RNA-seq of coding RNA from single cells (5)
ChIP-seq (4)
Methylation profiling by array (4)
Transcription profiling by RT-PCR (3)
DNA-seq (2)
RNA-seq of non coding RNA (2)
Transcription profiling by SAGE (1)
Unknown experiment type (1)
ChIP-chip by tiling array (1)
Animal - High-throughput sequencing (1)
Comparative genomic hybridization by array (1)
Other (1)
Proteomic profiling by array (1)
RNA-seq of total RNA (1)

Release Date

2022 (134)
2021 (115)
2025 (113)
2023 (112)
2024 (104)
2020 (82)
2015 (51)
2014 (51)
2019 (47)
2013 (46)
2018 (45)
2016 (43)
2017 (30)
2012 (30)
2026 (28)
2011 (27)
2010 (26)
2008 (24)
2009 (19)
2007 (8)
2006 (5)
2005 (4)

Previous page
1 / 151
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 151
Next page

Sort by:

Relevance

Page size

Fecal detection of calprotectin subunits links IBD activity with chronicity of intestinal inflammation.

Quantification of the human S100A8/S100A9 tetrameric protein complex in stool, referred to as fecal calprotectin, is an extensively validated biomarker supporting the diagnosis and management of gastrointestinal diseases1,2. The quaternary protein structures (called configuration here) of S100A8 and...

ORGANISM(S): Homo sapiens (Human)

2025-12-18 | PXD068250 | Pride

Proteomic profie of S100A9-immunoprecipitation

proteomic profie of S100A9-immunoprecipitation in human amnion fibroblasts

ORGANISM(S): Homo Sapiens

PXD054794 |

RNA sequencing of MOLM-13 and KG-1a cell lines after inhibition of S100A9 and BCL2

The aim is investigate the alterations in the transcriptome after combined inhibition of S100A9 and BCL2 in AML cell lines.

ORGANISM(S): Homo sapiens

2023-12-01 | E-MTAB-13095 | biostudies-arrayexpress

Biological effects of recombinant S100A8, recombinant S100A9, and recombinant S100A8/S100A9 on human renal tubular epithelial cells (HK-2)

PRJNA1104534 | ENA

Short-term blockade of pro-inflammatory alarmin S100A9 fa-vorably modulates left ventricle proteome and related signaling pathways involved in post – myocardial infarction recovery

Prognosis after myocardial infarction (MI) varies greatly depending of the extent of damaged area and the management of biological processes during recovery. Reportedly, the inhibition of the pro-inflammatory S100A9 reduces myocardial damage after MI. We hypothesize that S100A9 blockade induces chan...

ORGANISM(S): Mus musculus (Mouse)

2022-05-19 | PXD033683 | Pride

Hypertrophy Apoptosis Cardiac repair S100a9 Myocardial infarction

Mitochondrial Proteomics Uncovers Myeloid S100A9 Deficiency Promotes Liver Injury and Fibrosis Regression via Mitochondrial Metabolic Reprogramming of Macrophages

Macrophage-mediated inflammation has been implicated in the pathogenesis of liver fibrosis. Metabolic reprogramming involves in the transition of macrophages from a pro-inflammatory M1-phenotype toward an anti-inflammatory M2-phenotype. S100A9 is highly expressed in activated macrophages and promote...

ORGANISM(S): Mus Musculus

2025-11-03 | PXD070260 |

Neutrophil S100A9 supports M2 macrophage niche formation in granulomas

PRJNA684150 | ENA

The alarmin S100A9 hampers retroviral infection by limiting reverse transcription

PRJNA727578 | ENA

Platelet-derived S100A9 contributes to Endotheliopathy in Alcohol-Associated Hepatitis

PRJNA1471019 | ENA

Targeting S100A9 to inhibit the malignant progression of acute myeloid leukemia

PRJNA1294732 | ENA

Previous page
1 / 151
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 151
Next page

Sort by:

Relevance

Page size

1502 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Lab affiliation

Tags

IsPrivate

Submitter Keywords

Classification

Modification

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets